MolNFT v1 · #2335 · protein
Crystal structure of the extracellular domain of the type II activin receptor
1BTE · Protein (activin receptor type II): “Crystal structure of the extracellular domain of the type II activin receptor”. X-ray diffraction, 1 ligand (NAG). MolNFT v1 #2335 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 1BTE
- Type
- protein
- Length
- 186 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Protein (activin receptor type II)
- EC
- 2.7.1.-
- UniProt
- P27038
- Ligands
- NAG
Structure
x-ray diffraction · 2 distinct chains · 8% helix, 44% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Protein (activin receptor type II) (EC 2.7.1.-) | protein | 92 | 8% helix, 45% strand | P27038 |
| B | Protein (activin receptor type II) (EC 2.7.1.-) | protein | 94 | 7% helix, 44% strand | P27038 |
Ligands and binding sites
- NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 4 copies · chains A, B
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Modifications
Observed in the structure: 10 disulfide, 4 glycan (disulfide, N-glycosylation).
Compared structures
- 1BTE · Crystal structure of the extracellular domain of the type II activin receptor · the same entry in another collection · chain A against A, TM-score 1.00
- P27038 · AlphaFold monomer V2.0 prediction for activin receptor type-2A (P27038) · a predicted model of the same protein · chain B against A, TM-score 0.90
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P27038
- Elsewhere: RCSB PDB 1BTE · PDBe 1BTE · UniProt P27038
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.